999 related articles for article (PubMed ID: 2885336)
1. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
4. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
5. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
10. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment.
Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
Am J Perinatol; 1988 Apr; 5(2):152-8. PubMed ID: 2450549
[TBL] [Abstract][Full Text] [Related]
11. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
[TBL] [Abstract][Full Text] [Related]
12. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
Kasagi K; Hatabu H; Tokuda Y; Iida Y; Endo K; Konishi J
Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
[TBL] [Abstract][Full Text] [Related]
13. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
Mukuta T; Tamai H; Oshima A; Morita T; Matsubayashi S; Fukata S; Kuma K
Clin Endocrinol (Oxf); 1994 Feb; 40(2):215-9. PubMed ID: 7907955
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
Uno C; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory diagnosis before onset and prediction of Graves' disease].
Hidaka Y; Tada H; Amino N
Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
[TBL] [Abstract][Full Text] [Related]
17. The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
Bliddal H; Hegedüs L; Hansen JM; Bech K; van der Gaag R; Drexhage HA
Clin Endocrinol (Oxf); 1987 Jul; 27(1):75-84. PubMed ID: 2888551
[TBL] [Abstract][Full Text] [Related]
18. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
19. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
[TBL] [Abstract][Full Text] [Related]
20. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
